Is ABVC Biopharma Inc (ABVC) undervalued? · rev $509.6K
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This page asks whether ABVC Biopharma Inc (ABVC) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
ABVC currently screens at market cap $35.9M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ABVC 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ABVC to the stock page model before you treat a low multiple as a gift.
Not investment advice.